文献速递产科母胎医学

妊娠期糖尿病及其治疗对胎儿发育的短期和长期结局

Short- and long-term outcomes of gestational diabetes and its treatment on fetal development.
PubMed 文献 · Prenat Diagn · 2020-07-01

全球妊娠期糖尿病(GDM)患病率因母体肥胖增加而上升,筛查和诊断方法尚无共识。GDM对母亲、胎儿及子代有显著短期和长期健康风险,短期包括巨大儿、肩难产、产伤和产后低血糖,长期包括儿童及成年肥胖和心血管代谢风险增加。药物治疗包括胰岛素和口服降糖药二甲双胍和格列本脲,口服药短期儿童结局与胰岛素相似,但越来越多证据提示可能对宫内暴露子代有不良长期结局。未来研究应包含宫内暴露于降糖药物儿童的长期随访。

要点

  • GDM对胎儿短期风险包括巨大儿、肩难产、产伤和产后低血糖。
  • GDM子代长期风险包括儿童及成年肥胖和心血管代谢风险增加。
  • 口服降糖药短期儿童结局与胰岛素相似,但可能对子代有不良长期结局。

核心结论

  • GDM对母亲、胎儿及子代有显著短期和长期健康风险,口服降糖药可能对宫内暴露子代有不良长期结局,未来研究应包含长期随访以确定子代心血管代谢风险。

研究设计与样本

  • 综述,检索范围未在原文中报告。

主要发现

  • GDM胎儿短期风险包括巨大儿、肩难产、产伤和产后低血糖。
  • GDM子代长期风险包括儿童及成年肥胖和心血管代谢风险增加。
  • 口服降糖药二甲双胍和格列本脲的短期儿童结局与胰岛素相似,但越来越多证据提示可能对宫内暴露子代有不良长期结局。

关键数值与推荐

  • GDM筛查和诊断方法多种,但尚无共识。
  • GDM药物治疗包括胰岛素和口服降糖药二甲双胍和格列本脲。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Globally the prevalence of gestational diabetes mellitus (GDM) is rising mainly due to the increase in maternal obesity. A number of different methods to screen for and diagnose GDM have been described although consensus on the preferred methods does not yet exist. GDM has significant short- and long-term health risks for the mother, developing fetus and the children born to mothers with GDM. Short-term risks for the fetus include macrosomia (excessive birthweight), shoulder dystocia, birth trauma, and hypoglycaemia in the immediate postpartum period. Long-term risks for offspring born to mothers with GDM include increased rates of childhood and adulthood obesity and an increased cardiometabolic risk. A number of pharmacological treatments for GDM have been identified, these include insulin and oral glucose-lowering drugs metformin and glibenclamide. Whilst these oral glucose-lowering drugs show similar short-term childhood outcomes to insulin there is increasing evidence that these drugs may have adverse long-term outcomes on children and adults exposed to the drugs in utero. Future research on treatments for GDM should include long-term follow- up of children exposed to glucose lowering medication in utero to determine the long-term cardiometabolic risk in the offspring born to mothers with GDM.

来源:Prenat Diagn,查看原文。版权归原作者所有。

引用

  1. Murray SR, Reynolds RM. Short- and long-term outcomes of gestational diabetes and its treatment on fetal development. Prenat Diagn. 2020. PMID: 32946125. doi:10.1002/pd.5768

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。